Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
AUTOR(ES)
Mortensen, U H
RESUMO
Inhibition of eukaryotic DNA topoisomerase I by the minor groove binding ligand, distamycin A, was investigated. Low concentrations of the ligand selectively prevented catalytic action at a high affinity topoisomerase I binding sequence. A restriction enzyme protection assay indicated that the catalytic cycle was blocked at the binding step. Distamycin binding sites on DNA were localized by hydroxyl radical footprinting. A strongly preferred site mapped to a homopolymeric (dA).(dT)-tract partially included in the essential topoisomerase I binding region. Mutational elimination of the stable helix curvature associated with this ligand binding site demonstrated that (i) the intrinsic bend was unessential for efficient binding of topoisomerase I, and (ii) distamycin inhibition did not occur by deformation of a stable band. Alternative modes of inhibition are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=330672Documentos Relacionados
- Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature.
- Transcription-Dependent Degradation of Topoisomerase I-DNA Covalent Complexes
- Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.
- Processing of nucleopeptides mimicking the topoisomerase I–DNA covalent complex by tyrosyl-DNA phosphodiesterase
- Kinetics and thermodynamics of i-DNA formation: phosphodiester versus modified oligodeoxynucleotides.
